ProQR Therapeutics N.V. Net Fee Amt
ProQR Therapeutics N.V. (PRQR) had Net Fee Amt of $774.2 as of 2026-07-02, per its F-3 filed 2026-07-06.
Financial Statements › Notes
ffd:NetFeeAmt · last filed 2026-07-06
- 2026-07-02: Net Fee Amt $774.20.
| Period end | Net Fee Amt |
|---|---|
| 2026-07-02 | $774.20 F-3 · filed 2026-07-06 |